Search Results
Results found for "yA TZU LI"
- Molecular creativity in drug discovery
But what if the real opportunity lies in the chemical matter we throw at them? From cAMP to femtomolar ligands, she unpacks a career at the edge of precision signaling. Insights: • Receptor Localization Matters : Protein complexes pre-assemble at membranes, altering how ligands
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
While traditional drug discovery programs have focused on the development of ligands targeting the binding site of endogenous ligands (orthosteric site), allosteric modulators offer new avenues for the regulation identification of multiple allosteric sites and significantly enhanced our understanding of how allosteric ligands systematic analysis of the currently available GPCR structures in complex with small-molecule allosteric ligands in terms of the location of allosteric pockets, receptor-ligand interactions, and the chemical features
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands We selected the adenosine receptor 2B (A2BAR), specifically expressed in cancer cell lines compared with stromal cells, to explore the use of fluorescent ligands that can be used for target visualization. expression of A2BAR in CRC cell lines. As well, fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging
- Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses
We discuss ligand binding, signaling, and structures of the vGPCRs in light of robust differences from
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
In particular, focus lies on the mechanism behind the techniques, and the specific advantages and challenges that one should consider when attempting to compare functional outcomes from different studies, both linked to the specific assay mechanism and linked to its specific execution, as these may heavily impact the
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
cell-induced inflammation "Gut intraepithelial lymphocytes (IELs) are thought to calibrate glucagon-like peptide 1 (GLP-1) bioavailability, thereby regulating systemic glucose and lipid metabolism. -1RAs require the gut IEL GLP-1R to selectively restrain local and systemic T cell-induced, but not lipopolysaccharide-induced Such effects are mediated by the suppression of gut IEL effector functions linked to the dampening of These data reposition key roles of the L cell-gut IEL GLP-1R axis, revealing mechanisms linking GLP-1R
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
September 2022 "The complement fragment C5a is one of the most potent proinflammatory glycoproteins liberated C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 structure of C5aR2 and its interaction specificity toward C5a is not structurally elucidated in the literature
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Breakthroughs this week: Decoding ADGRE5 signaling; Eli Lilly’s obesity pill vs Novo’s Wegovy; Certa Metabolic GPCRs in the spotlight; receptor motion tracking tools; obesity treatment race between Eli Lilly From biased ligands to computational targeting, this is where the pipelines of the 2030s begin. DrGPCR University Attendee The difference between stalled programs and breakthrough therapies often lies
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
understanding why two drugs with similar affinity may behave completely differently , and how the secret lies Ligands don’t just “bind”—they change  the receptor. These sites don’t behave like traditional active sites. Ligands may take hours to equilibrate , even when they look potent on paper. What If the Same Site Behaves Differently Depending on the Ligand?
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
pro-inflammatory settings and clinical trials to treat idiopathic pulmonary fibrosis are currently ongoing using ligands
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
I would like to take this opportunity to thank all our French partners who trust us in the generation #technology #lifescience #immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies
- Innovative Data-Driven Solutions: The pHSense Revolution
These probes shift brightness and fluorescence lifetime as pH changes. Revvity commercial launch Building a Scalable Platform — Not a One-Off Assay The brilliance of pHSense lies “It’s like a funnel,” Trinquet explains. To hear the full story of how pHSense came to life—and why the GLP-1 data changed everything— 🎧 Listen GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
#biotech #lifesciences #appointment #GPCR #Oncology" Read more at the source #DrGPCR #GPCR #IndustryNews
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Liu S, Anderson PJ, Rajagopal S, Lefkowitz RJ, Rockman HA. Wodak SJ, Paci E, Dokholyan NV, Berezovsky IN, Horovitz A, Li J, et al. Motlagh HN, Wrabl JO, Li J, Hilser VJ. The ensemble nature of allostery. Shen S, Zhao C, Wu C, Sun S, Li Z, Yan W, et al. Truong ME, Bilekova S, Choksi SP, Li W, Bugaj LJ, Xu K, et al.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
Can we leverage structural and computational insights not just to explain receptor–ligand interactions after the fact, but to forecast outcomes and design ligands with new properties? When existing compounds are exhausted, bespoke ligands are designed and synthesized in-house. Common questions in the group include: Can we forecast ligand efficacy or selectivity? But part of their rigor lies in restraint.
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
of pharmacological judgment across the lifespan of a program. Key diagnostic considerations: Curved Schild plots suggest occupancy-limited modulation Linear plots advancement of scaffolds likely to collapse later “Fail early” is not pessimism. continually expanding on-demand archive Sustained exposure to disciplined mechanistic reasoning The value lies Explore the full library ➤
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
thoroughly investigated the role of single amino acid changes to clarify the molecular mechanisms governing ligand Rational Drug Design One immediate application of this research lies in rational drug design . Alternatively, allosteric modulators , which bind to sites outside the traditional ligand-binding pocket Interestingly, only 10 out of 82 important residues are within the ligand-binding pocket, resulting in Molecular determinants of ligand efficacy and potency in GPCR signaling.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Its strength lies not in complexity, but in the rigor of its simplicity. In the full lecture, Dr. Deviations—like reduced maximal responses or non-linear regressions—signal confounding kinetics, receptor Incomplete equilibration , where kinetics distort linearity. Each non-linearity is a coded message about the true mechanism. Explore the full library ➤
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
. 👉 Most founders don’t even realize they’re still running their company like an academic research group  ✅  This post explores how scientific thinking can become a leadership liability and what mindset But in the startup environment, these instincts can quickly become liabilities. Founders who keep operating like researchers often create internal confusion. It’s about realizing that your value now lies in decisions, not just in depth.  Â
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease The prevalence of non-alcoholic fatty liver disease (NAFLD) is globally increasing. Like many other organs, various GPCRs play a role in regulating liver function. It is predicted that more than 50 GPCRs are expressed in the liver. of the liver is very limited.
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
In particular, we focus on the application of on-cell NMR spectroscopy to characterize ligand interactions techniques allow for quantification of binding affinities, competitive binding assays, delineation of ligands involved in binding, ligand bound-state conformational determination, evaluation of receptor structuring and dynamics, and inference of distance constraints characteristic of the ligand-receptor bound state
- TLR4 biased small molecule modulators
Toll-like receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent
- Why Opposing Processes Matter for Your Next GPCR Drug
Drug pipelines live and die by your ability to make fast, accurate calls. One wrong assumption about how your molecule behaves in a living system can sink months of work and millions In this session, you’ll gain: ✅ A mental model you can trust  for predicting how GPCR ligands behave Every ligand you design enters a system that is already balancing opposing forces—vasoconstriction vs When In Vitro Lies: The Patient vs.
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
That gap leaves clinicians, first responders, and families without a reliable lifesaving tool in mixed With fentanyl, the danger lies in apneas —complete pauses in breathing. Naloxone’s Limits in the Age of Xylazine For decades, naloxone has been the trusted antidote for opioid First responders describe revivals that don’t feel like revivals, as if the body is still trapped in In other words, this is GPCR science with immediate, life-or-death consequences.
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why GPCR Events to keep you informed and engaged GPCR Jobs connecting candidates with positions Direct line This strategic decision to limit free content is essential as we need to increase revenue to support
- GPCR Collaboration: From Models to Medicine
For receptor assays and the biological interpretation of ligands, he relies on a network of collaborators The power of this design lies not in its independence but in its interdependence . predictions, especially when burned in the past by models that promised too much and delivered too little His group is trained to explain exactly what a model can predict and where its limits are. 🎧 Listen to the full episode on the Dr.
- Allosteric Binding Data Interpretation in Complex Receptor Systems
The ligand does not “block” or “replace” another ligand; it biases the population of receptor states. Kenakin attributes this to limited cooperativity: the allosteric ligand can only shift receptor affinity A cell line with limited coupling capacity may suppress the formation of key receptor states, masking The value of these models lies not in prediction alone, but in interpretation. allosteric ligand binding are examined in full—through weekly lectures by Dr.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Breakthroughs this week: FFA4 receptor signaling controls lipolysis at lipid droplets; novel atypical GPCR-arrestin complexes; Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average Career opportunities:  A curated list of new positions, including a Research Associate, a Senior Research If you’re not there, you’re missing out on the next wave of allosteric modulators, biased ligands, and This event is a critical opportunity to stay informed, but the real advantage lies in applying these
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
structural analysis of these complexes revealed two important aspects: the specific residues involved in ligand between the receptor-Gs and receptor-Gi complexes, suggesting that the selectivity of the G-protein lies Likewise, in this work the authors identify for the first time the specific amino acids that modulate subfamilies of class A GPCRs and potential therapeutic targets that are activated by the same endogenous ligand Check the original article at this link https://pubmed.ncbi.nlm.nih.gov/35714614/ *Above information
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
But drift does not live there. It lives in what is never questioned because it feels acceptable at the time. 👉 This kind of failure What looks like progress is often motion without alignment. The strategic advantage lies in leadership attention, not precision.

















